Annual Short Term Debt
$3.92 M
-$2.83 M-41.91%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual short term debt is $3.92 million, with the most recent change of -$2.83 million (-41.91%) on December 31, 2023.
- During the last 3 years, TBPH annual short term debt has fallen by -$25.28 million (-86.57%).
- TBPH annual short term debt is now -86.57% below its all-time high of $29.20 million, reached on December 31, 2020.
Performance
TBPH Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$4.20 M
-$23.00 K-0.55%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly short term debt is $4.20 million, with the most recent change of -$23.00 thousand (-0.55%) on September 30, 2024.
- Over the past year, TBPH quarterly short term debt has dropped by -$5.52 million (-56.80%).
- TBPH quarterly short term debt is now -85.63% below its all-time high of $29.20 million, reached on December 31, 2020.
Performance
TBPH Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
TBPH Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -41.9% | -56.8% |
3 y3 years | -86.6% | -69.0% |
5 y5 years | +100.0% | -85.6% |
TBPH Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -77.5% | at low | -75.9% | +506.4% |
5 y | 5-year | -86.6% | at low | -85.6% | +506.4% |
alltime | all time | -86.6% | -100.0% | -85.6% | -100.0% |
Theravance Biopharma Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $4.20 M(-0.5%) |
Jun 2024 | - | $4.22 M(+3.8%) |
Mar 2024 | - | $4.06 M(+3.6%) |
Dec 2023 | $3.92 M(-41.9%) | $3.92 M(-59.6%) |
Sep 2023 | - | $9.71 M(+6.0%) |
Jun 2023 | - | $9.16 M(+23.3%) |
Mar 2023 | - | $7.43 M(+10.0%) |
Dec 2022 | $6.75 M(-61.3%) | $6.75 M(+875.9%) |
Sep 2022 | - | $692.00 K(-73.6%) |
Jun 2022 | - | $2.62 M(-79.9%) |
Mar 2022 | - | $13.07 M(-25.1%) |
Dec 2021 | $17.44 M | $17.44 M(+28.8%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $13.55 M(+69.8%) |
Jun 2021 | - | $7.98 M(-38.1%) |
Mar 2021 | - | $12.88 M(-55.9%) |
Dec 2020 | $29.20 M(+65.8%) | $29.20 M(+201.5%) |
Sep 2020 | - | $9.69 M(+10.8%) |
Jun 2020 | - | $8.74 M(+9.9%) |
Mar 2020 | - | $7.95 M(-54.8%) |
Dec 2019 | $17.61 M(>+9900.0%) | $17.61 M(+13.4%) |
Sep 2019 | - | $15.53 M(-23.2%) |
Jun 2019 | - | $20.23 M(+143.8%) |
Mar 2019 | - | $8.30 M(>+9900.0%) |
Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Theravance Biopharma annual short term debt?
- What is the all time high annual short term debt for Theravance Biopharma?
- What is Theravance Biopharma annual short term debt year-on-year change?
- What is Theravance Biopharma quarterly short term debt?
- What is the all time high quarterly short term debt for Theravance Biopharma?
- What is Theravance Biopharma quarterly short term debt year-on-year change?
What is Theravance Biopharma annual short term debt?
The current annual short term debt of TBPH is $3.92 M
What is the all time high annual short term debt for Theravance Biopharma?
Theravance Biopharma all-time high annual short term debt is $29.20 M
What is Theravance Biopharma annual short term debt year-on-year change?
Over the past year, TBPH annual short term debt has changed by -$2.83 M (-41.91%)
What is Theravance Biopharma quarterly short term debt?
The current quarterly short term debt of TBPH is $4.20 M
What is the all time high quarterly short term debt for Theravance Biopharma?
Theravance Biopharma all-time high quarterly short term debt is $29.20 M
What is Theravance Biopharma quarterly short term debt year-on-year change?
Over the past year, TBPH quarterly short term debt has changed by -$5.52 M (-56.80%)